15
Participants
Start Date
January 22, 2021
Primary Completion Date
September 16, 2022
Study Completion Date
September 16, 2022
Melatonin
Participants will receive melatonin 5 mg once a day (30 min prior to bedtime) for four weeks, followed by one-week washout before crossing-over.
Placebo
Participants will receive placebo once a day (30 min prior to bedtime) for four weeks, followed by one-week washout before crossing-over.
The University of Texas Health Science Center at Houston, Houston
Huntington's Disease Society of America
OTHER
The University of Texas Health Science Center, Houston
OTHER